Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2132231A as adjuvant therapy in patients with resected melanoma
jRCT2080221174
- Sponsor
- GSK
- Start
- Aug 2010
- Modality
- Vaccines & Immunotherapeutics, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Trial of astuprotimut-R in melanoma, sponsored by GSK.
02
Drugs
astuprotimut-R
03
Conditions
melanoma
Beyond the preview
Go deeper on jRCT2080221174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221174.